DIAGNOS Welcomes Dr. Pierre-Luc Charlebois to its Advisory Board

BROSSARD, Quebec, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), announces that Dr. Pierre-Luc Charlebois has joined the Corporation’s Advisory Board.

Read more at globenewswire.com